These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26451069)

  • 21. Glycosylated hemoglobin A1c predicts coronary artery disease in non-diabetic patients.
    Kayali Y; Ozder A
    J Clin Lab Anal; 2021 Feb; 35(2):e23612. PubMed ID: 33034919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. General glycosylated hemoglobin goals potentially increase myocardial infarction severity in diabetes patients with comorbidities: Insights from a nationwide multicenter study.
    Che Q; Zhang Y; Wang J; Wan Z; Fu X; Chen J; Yan H; Chen Y; Ge J; Chen D; Huo Y
    J Diabetes Investig; 2020 Nov; 11(6):1498-1506. PubMed ID: 32383543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term prognostic utility of low-density lipoprotein (LDL) triglyceride in real-world patients with coronary artery disease and diabetes or prediabetes.
    Jin JL; Zhang HW; Cao YX; Liu HH; Hua Q; Li YF; Zhang Y; Guo YL; Wu NQ; Zhu CG; Xu RX; Gao Y; Li XL; Cui CJ; Liu G; Sun J; Dong Q; Santos R; Li JJ
    Cardiovasc Diabetol; 2020 Sep; 19(1):152. PubMed ID: 32981521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased serum glycated albumin level is associated with the presence and severity of coronary artery disease in type 2 diabetic patients.
    Pu LJ; Lu L; Shen WF; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Ding FH; Chen QJ; Shen J; Fang DH; Lou S
    Circ J; 2007 Jul; 71(7):1067-73. PubMed ID: 17587712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated lipoprotein (a) levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus.
    Zhang HW; Zhao X; Guo YL; Gao Y; Zhu CG; Wu NQ; Li JJ
    Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):980-986. PubMed ID: 30030022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycated albumin is more closely correlated with coronary artery disease than 1,5-anhydroglucitol and glycated hemoglobin A1c.
    Ma X; Hu X; Zhou J; Hao Y; Luo Y; Lu Z; Bao Y; Jia W
    Cardiovasc Diabetol; 2015 Feb; 14():16. PubMed ID: 25851542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated plasma myeloperoxidase levels in relation to circulating inflammatory markers in coronary artery disease.
    Samsamshariat SZ; Basati G; Movahedian A; Pourfarzam M; Sarrafzadegan N
    Biomark Med; 2011 Jun; 5(3):377-85. PubMed ID: 21657847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus.
    Yan X; Sano M; Lu L; Wang W; Zhang Q; Zhang R; Wang L; Chen Q; Fukuda K; Shen W
    Cardiovasc Diabetol; 2010 Oct; 9():70. PubMed ID: 21034455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations between glycated albumin or hemoglobin A1c and the presence of coronary artery disease.
    Norimatsu K; Miura S; Suematsu Y; Shiga Y; Miyase Y; Nakamura A; Yamada M; Matsunaga A; Saku K
    J Cardiol; 2015 Jun; 65(6):487-93. PubMed ID: 25107604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of C-reactive protein with body fat, diabetes and coronary artery disease in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-6).
    Mohan V; Deepa R; Velmurugan K; Premalatha G
    Diabet Med; 2005 Jul; 22(7):863-70. PubMed ID: 15975100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical utility of the ratio between circulating fibrinogen and fibrin (ogen) degradation products for evaluating coronary artery disease in type 2 diabetic patients.
    Xiong WX; Shen Y; Dai DP; Lu L; Zhang Q; Zhang RY; Shen WF; Tao R
    Chin Med J (Engl); 2015 Mar; 128(6):727-32. PubMed ID: 25758263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of glycemic state on postprandial hyperlipidemia and hyperinsulinemia in patients with coronary artery disease.
    Nakamura A; Monma Y; Kajitani S; Noda K; Nakajima S; Endo H; Takahashi T; Nozaki E
    Heart Vessels; 2016 Sep; 31(9):1446-55. PubMed ID: 26439243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visit-to-visit HbA
    Yang CD; Shen Y; Lu L; Yang ZK; Hu J; Zhang RY; Shen WF; Ding FH; Wang XQ
    Cardiovasc Diabetol; 2020 Sep; 19(1):133. PubMed ID: 32887588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fasting plasma glucose correlates with angiographic coronary artery disease prevalence and severity in Chinese patients without known diabetes.
    Gui MH; Li X; Lu ZQ; Gao X
    Acta Diabetol; 2013 Jun; 50(3):333-40. PubMed ID: 22684266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with no apparent coronary artery disease in patients with type 2 diabetes mellitus for more than 10 years of duration: a case control study.
    Srinivasan MP; Kamath PK; Bhat NM; Pai ND; Manjrekar PA; Mahabala C
    Cardiovasc Diabetol; 2015 Oct; 14():146. PubMed ID: 26521236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between insulin resistance, hyperglycemia, and coronary artery disease according to the presence of diabetes.
    Cho YR; Ann SH; Won KB; Park GM; Kim YG; Yang DH; Kang JW; Lim TH; Kim HK; Choe J; Lee SW; Kim YH; Kim SJ; Lee SG
    Sci Rep; 2019 Sep; 9(1):6129. PubMed ID: 31477741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidation-specific biomarkers, lipoprotein(a), and risk of fatal and nonfatal coronary events.
    Tsimikas S; Mallat Z; Talmud PJ; Kastelein JJ; Wareham NJ; Sandhu MS; Miller ER; Benessiano J; Tedgui A; Witztum JL; Khaw KT; Boekholdt SM
    J Am Coll Cardiol; 2010 Sep; 56(12):946-55. PubMed ID: 20828647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronary artery disease severity modifies associations between glycemic control and both mortality and myocardial infarction.
    Raghavan S; Liu WG; Michael Ho P; Plomondon ME; Barón AE; Caplan L; Joynt Maddox KE; Magid D; Saxon DR; Voils CI; Bradley SM; Maddox TM
    J Diabetes Complications; 2018 May; 32(5):480-487. PubMed ID: 29483016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma nesfatin-1 and DDP-4 levels in patients with coronary artery disease: Kozani study.
    Kadoglou NPE; Korakas E; Lampropoulos S; Maratou E; Kassimis G; Patsourakos N; Plotas P; Moutsatsou P; Lambadiari V
    Cardiovasc Diabetol; 2021 Aug; 20(1):166. PubMed ID: 34389003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrinogen is associated with glucose metabolism and cardiovascular outcomes in patients with coronary artery disease.
    Liu SL; Wu NQ; Shi HW; Dong Q; Dong QT; Gao Y; Guo YL; Li JJ
    Cardiovasc Diabetol; 2020 Mar; 19(1):36. PubMed ID: 32192491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.